Representing Sensus Healthcare for its proprietary low energy Photon Radiotherapy known as superficial radiation therapy SRT to treat non-melanoma skin cancers and keloids with its SRT-100™, SRT-100+™ and SRT-100 Vision™ systems. The SRT line offers innovative and revolutionary treatment options to enhance the quality of life of patients around the world.
SRT Vision is a superficial radiation therapy device that treats non-melanoma skin cancer and keloids without the need for surgery. The radiation is extremely accurate and only goes skin deep so as not to hurt any healthy tissue. The advanced high frequency ultra sound guidance system allows the physicians to see while they treat the cancerous cells.
SRT 100 is offered without the ultra sound function.
By delivering a precise, calibrated dose of Superficial Radiation Therapy that only goes skin deep, patients can be safely treated right in their physician’s office. Each treatment is virtually painless.
Low-dose Superficial Radiation Therapy effectively destroys basal cell carcinoma and squamous cell carcinoma, as well as the non-malignant tumor cells that cause keloids. Best of all, it doesn’t involve cutting, bleeding or stitching. With the SRT-100™, there is no need for anesthesia, minimal risk of infection or scarring, no need for reconstructive plastic surgery. Patients heal quickly and don’t have downtime or lifestyle restrictions following treatment.
SRT is available to qualified distributors in Middle East and North African markets for this innovative and non-invasive radiation therapy equipment.
